Medical Equipment

CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer's regorafenib

SUZHOU, China, Jan. 24, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) recently announced that it has dosed the first patient inAustralia in a clinical trial of CS1001, an investigational PD-L1 inhibitor developed by CStone, in combination with regorafenib, an...

2020-01-24 14:26 569

CyberMDX Research Team Discovers Collection of GE Medical Device Vulnerabilities -- "MDhex"

CISA ICS has Issued an Advisory Containing 6 High-Severity CVEs for GE CARESCAPE, ApexPro, and Clinical Information Center (CIC) systems NEW YORK, Jan. 24, 2020 /PRNewswire/ -- A collection of six cybersecurity vulnerabilities has been discovered in a range of GE Healthcare devices popular ...

2020-01-24 02:48 470

Argon Medical Announces the Commercial Launch of Two Inferior Vena Cava Filter Retrieval Kits

FRISCO, Texas, Jan. 22, 2020 /PRNewswire/ -- Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S. The Single-Loop and Triple-Loop Retrieval Kits are intended for percutaneous removal of retrievable inferior vena cava ...

2020-01-22 18:49 349

LABWorld China 2020 is Gearing Up

SHANGHAI, Jan. 22, 2020 /PRNewswire/ -- The National Medical Products Administration (NMPA) announced the first 45 key laboratories inJune 2019 and mentioned that the construction of national-level innovative key laboratories would play a guiding and demonstrated role in improving drug sci-tech ...

2020-01-22 11:37 354

3B Scientific Acquires iSimulate

HAMBURG, Germany, Jan. 21, 2020 /PRNewswire/ -- Today, 3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and the world's leading manufacturer and marketer of anatomical models and medical simulation products for healthcare and patient education, announced that it has entere...

2020-01-21 03:07 586

Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team

HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- The leading transcatheter heart valve medical device player inChina - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", stock code: 2500.HK), today is pleased to announce the appointment of two new cardiovascular experts to its advisor...

2020-01-20 18:04 5642

Mindray Launches New TE7 ACE Point-of-Care Solution to Improve Diagnostic Confidence

SHENZHEN, China, Jan. 20, 2020 /PRNewswire/ -- Mindray Medical (SZSE: 300760), a leading global provider of medical devices and solutions, announces the release of its new Point-of-Care Ultrasound System,TE7 ACE . This new Touch Screen Ultrasound ...

2020-01-20 16:00 352

LimaCorporate Inaugurates the New Research & Innovation Center for 3D Printing and the Advanced Laboratory for Testing and Analysis (ATLAs)

UDINE, Italy, Jan. 16, 2020 /PRNewswire/ -- LimaCorporate announces the official opening of new spaces entirely dedicated to 3D Printing and advanced testing: the Research & Innovation Center (R&I Center) and the Advanced Laboratory for Testing and Analysis (ATLAs). These new areas are located in...

2020-01-16 21:00 590

ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China

SAN CARLOS, California, Jan. 14, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced that its ZAP-X® Gyroscopic Radiosurgery™ platform began clinical stereotactic radiosurgery (SRS) treatments at PLA General Hospital 301 (PLAGH 301) inBeijing, China. PLAGH 301 is the largest hospital ...

2020-01-14 23:07 449

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

LONDON, Jan. 13, 2020 /PRNewswire/ -- COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The patent covers...

2020-01-13 19:05 328

Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe

Improved scan rates, higher resolution, and heightened sensitivity attract more verticals towards mass spectroscopy, finds Frost & Sullivan LONDON, Jan. 13, 2020 /PRNewswire/ -- A recent analysis of the mass spectrometry (MS) market inEurope by Frost & Sullivan has revealed that the sector will ...

2020-01-13 16:02 397

Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)

The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss. CAMBRIDGE, England, Jan. 13, 2020 /PRNewswire/ -- Exonate, an early stage biotechnology com...

2020-01-13 16:00 412

Skyrocketing growth tipped for China Medical industry over next 5 years; Medtec China 2020 upgrades to two halls to meet market needs

SHANGHAI, Jan. 13, 2020 /PRNewswire/ -- According to a forecast from CIConsulting, the revenue ofChina's medical equipment and manufacturing industry will reachCNY327.4 billion in 2019, the average annual compound growth rate over the next five years will be about 8.15%, and the market will reach...

2020-01-13 09:00 474

VISTA Eye Specialist bringing vision correction to a whole breakthrough level of safety

KUALA LUMPUR, Malaysia, Jan. 10, 2020 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of the premier and largest eye specialist inMalaysia, announces the introduction of No-Blade ICL, a combination of the Ziemer LDV Z8 Femtosecond Laser and the Visian EVO ICL. Placed within the eye, the ICL hel...

2020-01-10 17:32 746

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio(TM)

SANTA CLARA, Calif., Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 North American Technology Innovation Award for its Cala Trio™, a prescription-only, wrist-worn d...

2020-01-09 22:00 470

Alma, a Sisram Medical Company, Launches DermaClear 3-in-1 Skin Hydradermabrasion Platform

NUREMBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced the launch of DermaClear, a powerful 3-in-1 treatment solution for deep cleansing, nourishment, and hydration of facial skin.   DermaClear i...

2020-01-09 17:00 498

Alma, a Sisram Medical Company, Receives Excellence Award for "Outstanding Business Performance in Japan"

NURNBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced it has been recognized with an Excellence Award for its "outstanding business performance inJapan" in 2019. The annual "Excellence Award" was...

2020-01-09 10:00 654

Symmetry Surgical, Inc. Acquires The O.R. Company

Acquisition strengthens Symmetry's commitment to deliver best-in-class, cost-effective solutions NASHVILLE, Tennessee, Jan. 9, 2020 /PRNewswire/ -- Symmetry Surgical, Inc. ("Symmetry"), is pleased to announce that it has completed its acquisition of The O.R. Company. The O.R. Company develops, m...

2020-01-09 00:37 425

CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma

SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients wit...

2020-01-08 13:45 1182

Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies

LONDON, Jan. 8, 2020 /PRNewswire/ -- Rapid Diagnostics ML Limited, UK is pleased to announce the return of its Point of Care (PoC) platform, the MiniLab System. Rapid was formed to purchase the assets and Intellectual Property (IP) of the former Enigma Diagnostics, which was liquidated in 2017. ...

2020-01-08 08:00 446
12345 ... 54